Sapient
Biomarker discovery organization accelerating drug development through rapid, large-scale small molecule biomarker profiling.
About Sapient
Sapient enables the discovery of circulating small molecule biomarkers at unprecedented speed and scale. Leveraging next-generation mass spectrometry, biocomputational analysis, and large-scale human biology databases, its platform supports the rapid identification and validation of circulating biomarkers of health, disease, and drug response which are needed to align patients, disease biology, and specific therapies.
Company Facts
- Headquarters
- San Diego
- Operating Status
- active
- Company Type
- for_profit
- IPO Status
- private
- Employees
- c_00051_00100
- Total Funding
- $13,803,306
- Last Funding Type
- grant
- Last Funding Date
- 2022-07-11
- Website
- sapient.bio
Industries & Categories
Biotechnology, Clinical Trials, Life Science, Pharmaceutical
Social Links
Canonical: https://fsome.com/organization/sapient-34321 · For the full interactive profile (funding rounds, investors, team, portfolio, charts), please enable JavaScript.